Literature DB >> 20040347

The relationship between serum level of N-terminal pro-B-type natriuretic peptide and nutritional status, and inflammation in chronic hemodialysis patients.

A Bednarek-Skublewska1, W Zaluska, A Ksiazek.   

Abstract

BACKGROUND: N-terminal pro-B-type natriuretic peptide (NT-pro BNP), a biomarker of heart failure, is involved in regulation of the body fluid homeostasis and vascular tone. The purpose of this study was to investigate the relationship between serum level of NT-pro BNP and nutritional status, inflammation and hydration in patients on maintenance hemodialysis (HD).
MATERIALS AND METHODS: The study involved 97 HD patients (mean age: 65.3 +/- 13.9 years, HD duration: 36.3 +/- 43.5 months). Blood tests comprised the measurements of serum levels of NT-pro BNP, interleukin-6 (IL-6), human soluble tumor necrosis factor receptor I (s TNF RI), hemoglobin (Hb), albumin (alb) and urea. Furthermore, normalized protein catabolic rate (n PCR), body mass index (BMI), mean arterial blood pressure (MAP), adequacy of HD (Kt/V), and interdialytic body weight gain (IBWG) were calculated. In addition, NT-pro BNP was measured in a healthy control group (CG; n = 24, mean age 49.5 +/- 15.0 years). Hydration status was determined by bioimpedance analysis (BIA).
RESULTS: Irrespective of gender, NT-pro BNP levels were markedly elevated in HD patients compared with CG (15879.2 +/- 14033.3 pg/ml vs. 73.45 +/- 23.56 pg/ml; p < 0.00001). NT-pro BNP was unrelated to any measures of body fluid compartments. Multivariate regression analysis revealed that only four parameters (nPCR, Hb, MAP, and total time on HD) influenced serum NT-pro BNP levels.
CONCLUSION: While there was only moderate direct association of NT-pro BNP with hydration status, it was elevated in patients with intensive catabolism, severe anemia, higher MAP and longer total duration of HD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20040347     DOI: 10.5414/cnp73014

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

1.  Brain Natriuretic Peptide Is a Marker of Fluid Overload in Incident Hemodialysis Patients.

Authors:  Charles Chazot; Margaux Rozes; Cyril Vo-Van; Patrik Deleaval; Jean-Marc Hurot; Christie Lorriaux; Brice Mayor; Eric Zaoui; Guillaume Jean
Journal:  Cardiorenal Med       Date:  2017-04-29       Impact factor: 2.041

2.  In-hospital and long-term outcomes of congestive heart failure: Predictive value of B-type and amino-terminal pro-B-type natriuretic peptides and their ratio.

Authors:  Yuxiang Dai; Jun Yang; Atsutoshi Takagi; Hakuoh Konishi; Tetsuro Miyazaki; Hiroshi Masuda; Kazunori Shimada; Katsumi Miyauchi; Hiroyuki Daida
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

3.  Investigation of optimum N-terminal probrain natriuretic peptide level in patients on maintained hemodialysis.

Authors:  Lan Chen; Ying-Ying Chen; Yi-Sheng Ling; Chun-Hua Lin; Jin-Xuan He; Tian-Jun Guan
Journal:  Ren Fail       Date:  2017-11       Impact factor: 2.606

Review 4.  N-terminal Pro-B-Type Natriuretic Peptide and Malnutrition in Patients on Hemodialysis.

Authors:  Jacques Ducros; Laurent Larifla; Henri Merault; Valérie Galantine; Valérie Bassien-Capsa; Lydia Foucan
Journal:  Int J Nephrol       Date:  2020-03-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.